marginally significantp = 0.079
There was also a marginally significant decline ( p = 0.079) in MAR within the cancer-injected limb at 36 days compared with 18 days post-injection (0.91μm/d ± 0.12).
There was also a marginally significant decline ( p = 0.079) in MAR within the cancer-injected limb at 36 days compared with 18 days post-injection (0.91μm/d ± 0.12).
Although there was a trend to suggest that the bone formation rate per surface (BFR/BS) was lower in the cancer-injected limbs compared to the control limbs at 36 days post-injection ( Table 2 ), the difference between the two treatment groups did not reach statistical significance.